Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis

INTRODUCTION: Interstitial lung disease (ILD) is a common manifestation of scleroderma/systemic sclerosis (SSc). However, the direct and indirect economic burdens of SSc-ILD remain unclear. This study assessed and compared healthcare resource utilization (HRU), direct healthcare costs, work loss, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhou, Fan, Yanni, Thomason, Darren, Tang, Wenxi, Liu, Xinyue, Zhou, Zheng-Yi, Macaulay, Dendy, Fischer, Aryeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824377/
https://www.ncbi.nlm.nih.gov/pubmed/30929184
http://dx.doi.org/10.1007/s12325-019-00929-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824377/
https://www.ncbi.nlm.nih.gov/pubmed/30929184
http://dx.doi.org/10.1007/s12325-019-00929-2

Ejemplares similares